Neurosurgical management of Myelomeningocele in premature infants: a case series.

Abstract

Myelomeningocele (MMC) is the most common neural tube defect, but rarely seen in premature infants. Most centers advocate for closure of MMC within 24h of birth. However, this is not always possible in severely premature infants. Given the rarity of this patient population, we aimed to share our institutional experience and outcomes of severely premature infants with MMC. We performed a retrospective, observational review of premature infants (≤ 32weeks gestational age) identified through our multidisciplinary spina bifida clinic (1995-2021) and surgical logs. Descriptive statistics were compiled about this sample including timing of MMC closure and incidence of adverse events such as sepsis, CSF diversion, meningitis, and death. Eight patients were identified (50% male) with MMC who were born ≤ 32weeks gestational age. Mean gestational age of the population was 27.3weeks (SD 3.5). Median time to MMC closure was 1.5days (IQR = 1-80.8). Five patients were taken for surgery within the recommended 48h of birth; 2 patients underwent significantly delayed closure (107 and 139days); and one patient's defect epithelized without surgical intervention. Six of eight patients required permanent cerebrospinal fluid (CSF) diversion (2 patients were treated with ventriculoperitoneal shunting (VPS), three were treated with endoscopic third ventriculostomy (ETV) with choroid plexus cauterization (CPC) and 1 patient treated with ETV; mean of 3years after birth, ranging from 1day to 16years). Two patients required more than one permanent CSF diversion procedure. Two patients developed sepsis (defined as meeting at least 2/4 SIRS criteria). In both cases of sepsis, patients developed signs and symptoms more than 72h after birth. Notably, both instances of sepsis occurred unrelated to operative intervention as they occurred before permanent MMC closure. Two patients had intraventricular hemorrhage (both grade III). No patients developed meningitis (defined as positive CSF cultures) prior to MMC closure. Median follow up duration was 9.7years. During this time epoch, 3 patients died: Two before 2years of age of causes unrelated to surgical intervention. One of the two patients with grade III IVH died within 24h of MMC closure. In our institutional experience with premature infants with MMC, some patients underwent delayed MMC closure. The overall rate of meningitis, sepsis, and mortality for preterm children with MMC was similar to MMC patients born at term.